Middletown, NJ, United States of America

Richard J Kascsak

This inventor holds 1 USPTO granted patent. Top assignee: Research Foundation of Mental Hygiene Inc.. Active years: 1989.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Richard J Kascsak. Retrieved from https://idiyas.com/inventor/richard-j-kascsak

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 35(Granted Patents)


Company Filing History:


Years Active: 1989

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Richard J Kascsak: Innovator in Monoclonal Antibody Production

Introduction

Richard J Kascsak is a notable inventor based in Middletown, NJ (US). He has made significant contributions to the field of biotechnology, particularly in the production of monoclonal antibodies. His work has implications for various medical applications, including research into prion diseases.

Latest Patents

Richard J Kascsak holds a patent for a hybrid cell line that produces monoclonal antibodies directed against the hybridoma tumor cell line ATCC No. HB9222. This monoclonal antibody is specific for scrapie-associated fibrils and the proteins that comprise these fibrils. His innovative approach has the potential to advance the understanding and treatment of prion-related conditions.

Career Highlights

Kascsak is affiliated with the Research Foundation of Mental Hygiene Inc., where he continues to explore advancements in his field. His dedication to research and development has positioned him as a key figure in the study of monoclonal antibodies.

Collaborations

Throughout his career, Richard J Kascsak has collaborated with esteemed colleagues, including Richard Rubenstein and Patricia A Merz. These partnerships have fostered a collaborative environment that enhances the research output and innovation in their projects.

Conclusion

Richard J Kascsak's contributions to the field of monoclonal antibody production exemplify the impact of innovative research in biotechnology. His work continues to influence the scientific community and offers promising avenues for future medical advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…